VETMEDIN CHEW 이탈리아 - 이탈리아어 - Ministero della Salute

vetmedin chew

boehringer ingelheim vetmedica gmbh - pimobendan - pimobendan - 2.5 milligrammo (i), pimobendan - 1.25 milligrammo (i), pimobendan - 5 milligrammo (i), pimobendan - 5 mg, pimobendan - 1.25 mg, pimobendan - 2.5 mg, pimobendan - 10 mg - pimobendan

ZELYS -COMPRESSE MASTICABILI PER CANI 이탈리아 - 이탈리아어 - Ministero della Salute

zelys -compresse masticabili per cani

ceva salute animale s.p.a. - pimobendan - pimobendan - 1.25 milligrammo (i), pimobendan - 5 mg, pimobendan - 1.25 mg, pimobendan - 10 mg - pimobendan

CARDISURE FLAVOURED 이탈리아 - 이탈리아어 - Ministero della Salute

cardisure flavoured

eurovet animal health b.v. - pimobendan - pimobendan - 1.25 milligrammo (i), pimobendan - 10 milligrammo (i), pimobendan - 5 milligrammo (i), pimobendan - 2.5 milligrammo (i), pimobendan - 10 mg, pimobendan - 1.25 compressa, pimobendan - 1.25 mg, pimobendan - 5 mg, pimobendan - 2.5 mg - pimobendan

VETMEDIN 이탈리아 - 이탈리아어 - Ministero della Salute

vetmedin

boehringer ingelheim vetmedica gmbh - pimobendan - pimobendan - 5 milligrammo (i), pimobendan - 5 mg, pimobendan - 1.25 mg, pimobendan - 2.5 mg - pimobendan

Aldara 유럽 연합 - 이탈리아어 - EMA (European Medicines Agency)

aldara

viatris healthcare limited - imiquimod - condylomata acuminata; keratosis; keratosis, actinic; carcinoma, basal cell - antibiotici e chemioterapici per uso dermatologico - imiquimod cream is indicated for the topical treatment of :external genital and perianal warts (condylomata acuminata) in adults. small superficial basal cell carcinomas (sbccs) in adults. clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (aks) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.

Aimovig 유럽 연합 - 이탈리아어 - EMA (European Medicines Agency)

aimovig

novartis europharm limited - erenumab - emicrania - analgesici - aimovig è indicato per la profilassi dell'emicrania negli adulti che hanno almeno 4 emicrania giorni al mese quando iniziare il trattamento con aimovig.